One prominent genetic molecular abnormality in AML, is the occurrence of internal tandem duplications (ITD) in the FMS-like tyrosine kinase 3 (FLT3) receptor gene, affecting 25–30% of patients. The gene discussed is FLT3; the disease is acute myeloid leukemia.